Piperazine → HCID 12108585, compound
Reaction equation
CS(OCCC[C:9]1[CH:18]=[CH:17][C:16]2[C:11](=[CH:12][C:13]([O:23][CH3:24])=[C:14]([O:21][CH3:22])[C:15]=2[O:19][CH3:20])[CH:10]=1)(=O)=O.[NH:25]1[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]1>>[CH3:20][O:19][C:15]1[C:14]([O:21][CH3:22])=[C:13]([O:23][CH3:24])[CH:12]=[C:11]2[C:16]=1[CH:17]=[CH:18][C:9]([CH2:10][CH2:9][CH2:18][N:25]1[CH2:30][CH2:29][N:28]([CH2:12][CH2:11][CH2:16][C:9]3[CH:18]=[CH:17][C:16]4[C:11](=[CH:12][C:13]([O:23][CH3:24])=[C:14]([O:21][CH3:22])[C:15]=4[O:19][CH3:20])[CH:10]=3)[CH2:27][CH2:26]1)=[CH:10]2Participants
3
Procedure
2-(3-Methanesulfonyloxypropyl)-5,6,7-trimethoxynaphthalene (213 mg) and piperazine (26 mg) were reacted in the same manner in Example 1 to obtain the title compound as a free base.
Sources & evidence
- ORD record
- ord-23f2d3bd301a4e4ab559a4606b88e37d
- Source dataset
- uspto-grants-2006_11
- Patent number
- US07135473B2
Reaction notes
Loading…